Sabinsa, the multi-national health science company known for providing sustainable natural, well-researched ingredients, announces the addition of staff in the United States and the promotion of a long-time team member.

Sabinsa, the multi-national health science company known for providing sustainable natural, well-researched ingredients, announces opening a new region with the addition of staff in Russia and South America.

Sabinsa, the multi-national health science company known for providing sustainable natural, well-researched ingredients, announces Dr. K Srinivasa Reddy as Sami-Sabinsa Group Director of Quality & Regulatory. Dr. Srinivasa will drive the Quality initiatives across the organization and its subsidiaries, including oversight of quality control, quality assurance, microbiology, clinical trials, and regulatory compliance for formulation and ingredients. He is based at the Sami-Sabinsa Group corporate office in Bangalore, India.

Sabinsa, the multi-national health science company known for providing sustainable natural, well-researched ingredients, announces that industry veteran Jeanette Fisher, RDN has joined the management team as Marketing Director. Jeanette brings in-depth knowledge of marketing, sales, nutrition, customer service, regulatory affairs, QA compliance, purchasing, and R&D.

Shaheen Majeed, Global CEO & Managing Director of Sami-Sabinsa Group, has been elected as Vice Chairman of the Confederation of Indian Industry National Committee on Intellectual Property Rights (2024-25).

Shaheen Majeed, Global CEO, to Speak on Lessons Learned in the Lab

Sabinsa, the multi-national health science company known for sustainable, natural, well-researched ingredients, will exhibit at SupplySide West, October 30 – 31, 2024, Mandalay Bay in Las Vegas, Nevada. Scientists will be available in booth #4647 to describe Sabinsa’s top selling products in the fastest growing categories, all supported by clinical studies and Sabinsa’s deep commitment to quality.

Sabinsa, a global leader in the nutraceutical and cosmeceutical industries, has had another clinical study on the heat-stable probiotic LactoSpore® [Weizmannia coagulans (Bacillus coagulans) MTCC 5856] published, adding to the robust body of science on this well-established ingredient.